Evidence map›Paper›PMID 37110232›Full record

ArticleMetabolites2023

Hospitalization Burden of Patients with Kidney Stones and Metabolic Comorbidities in Spain during the Period 2017-2020.

Javier Sáenz-Medina, Jesús San Román, María Rodríguez-Monsalve, Manuel Durán, Joaquín Carballido, Dolores Prieto, Ángel Gil Miguel

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Javier Sáenz-MedinaDepartment of Urology, Puerta de Hierro-Majadahonda University Hospital, 28222 Madrid, Spain.ORCID 0000-0002-8568-854X
Jesús San RománDepartment of Medical Specialties and Public Health, King Juan Carlos University, 28922 Madrid, Spain.
María Rodríguez-MonsalveDepartment of Urology, Puerta de Hierro-Majadahonda University Hospital, 28222 Madrid, Spain.ORCID 0000-0001-6599-4614
Manuel DuránDepartment of Medical Specialties and Public Health, King Juan Carlos University, 28922 Madrid, Spain.ORCID 0000-0002-4335-7208
Joaquín CarballidoDepartment of Urology, Puerta de Hierro-Majadahonda University Hospital, 28222 Madrid, Spain.
Dolores PrietoDepartment of Physiology, Pharmacy Faculty, Complutense University, 28040 Madrid, Spain.ORCID 0000-0001-7049-5991
Ángel Gil MiguelDepartment of Medical Specialties and Public Health, King Juan Carlos University, 28922 Madrid, Spain.ORCID 0000-0003-1295-7101
Universidad Rey Juan Carlos · ESHospital Universitario Puerta de Hierro Majadahonda · ESUniversidad Complutense de Madrid · ES

Funding

Asociación Española de Urología 2017Ministerio de Ciencia e Innovación PID2019-105689RB
6 · The paper itself

Abstract

Nephrolithiasis has become an increasing worldwide problem during the last decades. Metabolic syndrome, its components, and related dietary factors have been pointed out as responsible for the increasing incidence. The objective of this study was to evaluate the trends in the hospitalization rates of patients with nephrolithiasis, hospitalization features, costs, and how metabolic syndrome traits influence both the prevalence and complications of lithiasic patients. An observational retrospective study was conducted by analyzing hospitalization records from the minimum basic data set, including all patient hospitalizations in Spain in which nephrolithiasis has been coded as a main diagnosis or as a comorbidity during the period 2017-2020. A total of 106,407 patients were hospitalized and coded for kidney or ureteral lithiasis in this period. The mean age of the patients was 58.28 years (CI95%: 58.18-58.38); 56.8% were male, and the median length of stay was 5.23 days (CI95%: 5.06-5.39). In 56,884 (53.5%) patients, kidney or ureteral lithiasis were coded as the main diagnosis; the rest of the patients were coded mostly as direct complications of kidney or ureteral stones, such as "non-pecified renal colic", "acute pyelonephritis", or "tract urinary infection". The hospitalization rate was 56.7 (CI95%: 56.3-57.01) patients per 100,000 inhabitants, showing neither a significant increasing nor decreasing trend, although it was influenced by the COVID-19 pandemic. The mortality rate was 1.6% (CI95%: 1.5-1.7), which was higher, if lithiasis was coded as a comorbidity (3.4% CI95%: 3.2-3.6). Metabolic syndrome diagnosis component codes increased the association with kidney lithiasis when age was higher, reaching the highest in the eighth decade of life. Age, diabetes, and hypertension or lithiasis coded as a comorbidity were the most common causes associated with the mortality of lithiasic patients. In Spain, the hospitalization rate of kidney lithiasis has remained stable during the period of study. The mortality rate in lithiasic patients is higher in elderly patients, being associated with urinary tract infections. Comorbidity conditions such as diabetes mellitus and hypertension are mortality predictors.

Indexed as

epidemiologymetabolic syndromeurolithiasis

Identifiers

PMID37110232
PMCPMC10142441
OpenAlexW4366277653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.